Formulation Strategies for Poorly Soluble Drugs

Drug Manufacturers, Technology

Formulation Strategies for Poorly Soluble Drugs

By Patheon

With the advent of combinatorial chemistry and high throughput screening, the number of poorly water soluble drug candidates has dramatically increased. The "drugability" of new chemical entities (NCEs) and life-cycle management of marketed pharmaceutical products are becoming more challenging.

The American Association of Pharmaceutical Scientists (AAPS) Formulation Design & Development (FDD) section organized an open forum, which took place immediately following the 2010 AAPS Annual Meeting and Exposition, to address the formulation strategies for poorly soluble drugs.

Please download this free white paper for more information.

Enter your details below to view the free white paper

By downloading this whitepaper, you acknowledge that GlobalData may share your information with our white paper partners/sponsors who may contact you directly with information on their products and services.

Visit our for more information about our services, how GlobalData may use, process and share your personal data, including information on your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

网曝门